The global peptide therapeutics market size has been estimated at USD 52.59 billion in 2025 and is expected to reach around USD 83.75 billion by 2034, growing at a CAGR of 5.31% from 2025 to ...

Advanced Ovarian Cancer Pipeline Insights LAS VEGAS, NV, UNITED STATES, February 12, 2025 /EINPresswire / -- As per DelveInsight's assessme ...

For decades, scientists across the globe have investigated methods to accurately measure drug permeability across the blood-brain barrier, a compact layer of cells that protect the brain from ...

The global biopharmaceutical drug delivery technologies market is projected to grow at a CAGR of 7.75%, reaching an expected revenue of USD 335.8 US, NY, UNITED STATES, January 30, 2025 /EINPresswire ...

WASHINGTON — President Trump began his second term Monday with a sweeping order aimed at reversing dozens of former President Biden’s top priorities, from regulations aimed at lowering health ...

The directive was first reported by The Washington Post. Representatives of the C.D.C. and the Food and Drug Administration declined to comment. The moratorium is to continue through Feb. 1.

In patients with out-of-hospital cardiac arrest, securing intravenous access for drug delivery is challenging. Whether the intraosseous route can improve clinical outcomes has been uncertain.

Many of the health benefits listed in the new paper are known. The U.S. Food and Drug Administration (FDA) recently approved adding to Wegovy's label that the drug can also reduce the risk of ...

Parenteral Drugs India Ltd's Revenue of - is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats: ...

Formally, these drugs are known as glucagon-like peptide-1 receptor agonists (GLP-1RA) and include Mounjaro and Zepbound. Informally, media, patients and even some physicians have dubbed GLP-1 ...

Parenteral Drugs (India) Ltd is a pharmaceutical company. It is principally engaged in manufacturing pharmaceutical preparations. The company manufactures products in categories like intravenous (IV) ...

The Biden administration, in its last full weekday in office, announced the next 15 drugs up for Medicare price negotiation. Blockbuster diabetes drug Ozempic is on the list. That means the ...